Viewing Study NCT01594918


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-06-06 @ 9:09 PM
Study NCT ID: NCT01594918
Status: COMPLETED
Last Update Posted: 2017-07-21
First Post: 2012-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer
Sponsor: Rahul Aggarwal
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration-resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic View
None CRPC View
None prostate View
None CAMP View